You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Neurogenic detrusor overactivity

Showing 1 - 25 of 643
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neurogenic Detrusor Overactivity Trial in Worldwide (mirabegron)

Not yet recruiting
  • Neurogenic Detrusor Overactivity
  • Palo Alto, California
  • +11 more
Jan 16, 2023

Neurogenic Bladder, Lower Urinary Tract Symptoms, Overactive Bladder Trial (Standard number of injection sites, Reduced number

Not yet recruiting
  • Neurogenic Bladder
  • +4 more
  • Standard number of injection sites
  • Reduced number of injection sites
  • (no location specified)
Sep 22, 2023

Triggered Sacral Neuromodulation for Neurogenic Bladder

Recruiting
  • Urinary Incontinence
  • Urinary Bladder, Neurogenic
  • UroMonitor
  • ASCU
  • Cleveland, Ohio
    Louis Stokes VA Medical Center, Cleveland, OH
Nov 15, 2022

Neurogenic Detrusor Overactivity Trial (Vibegron)

Not yet recruiting
  • Neurogenic Detrusor Overactivity
  • (no location specified)
Aug 4, 2022

Spinal Cord Injuries, Neurogenic Bladder, Neurogenic Detrusor Overactivity Trial (Neuromodulation)

Not yet recruiting
  • Spinal Cord Injuries
  • +3 more
  • Neuromodulation
  • (no location specified)
Aug 12, 2022

Neurogenic Detrusor Overactivity Trial in Colombia, United States (Darifenacin)

Terminated
Has Results
  • Neurogenic Detrusor Overactivity
  • San Diego, California
  • +11 more
May 13, 2022

Neurogenic Detrusor Overactivity Trial in Worldwide (Mirabegron)

Completed
Has Results
  • Neurogenic Detrusor Overactivity
  • Randwick, New South Wales, Australia
  • +31 more
Sep 21, 2022

Overactive Bladder, Neurogenic Detrusor Overactivity Trial in Aalborg, Aarhus, Warsaw (mirabegron)

Completed
  • Overactive Bladder
  • Neurogenic Detrusor Overactivity
  • Aalborg, Denmark
  • +2 more
Jun 28, 2021

Spinal Cord Injury, Acute Trial in Switzerland (VERUM TTNS, SHAM TTNS)

Recruiting
  • Spinal Cord Injury, Acute
  • VERUM TTNS
  • SHAM TTNS
  • Basel, Switzerland
  • +3 more
Oct 21, 2022

Urinary Bladder, Overactive Trial in Japan (GSK1358820, Placebo)

Completed
Has Results
  • Urinary Bladder, Overactive
  • Aomori, Japan
  • +8 more
Jul 13, 2021

Neurogenic Detrusor Overactivity, Overactive Bladder, Pharmacokinetics of Mirabegron Trial in Worldwide (Mirabegron)

Completed
  • Neurogenic Detrusor Overactivity
  • +2 more
  • Edegem, Belgium
  • +12 more
Jul 13, 2021

Neurogenic Detrusor Overactivity Trial in Worldwide (Rec 0/0438 1 mg or Rec 0/0438 2 mg, )

Completed
  • Neurogenic Detrusor Overactivity
  • Rec 0/0438 1 mg or Rec 0/0438 2 mg
  • placebo
  • Praha, Czechia
  • +8 more
Jan 26, 2021

Neurogenic Urinary Bladder, Neurogenic Bladder Disorder, Neurogenic Dysfunction of the Urinary Bladder Trial in Murnau,

Terminated
  • Neurogenic Urinary Bladder
  • +4 more
  • Murnau, Germany
  • +2 more
Dec 11, 2020

Urinary Bladder, Neurogenic Trial in Japan (Fesoterodine PR 4 mg, Fesoterodine PR 8 mg, Fesoterodine BIC 2 mg)

Completed
Has Results
  • Urinary Bladder, Neurogenic
  • Fesoterodine PR 4 mg
  • +3 more
  • Obu, Aichi, Japan
  • +6 more
Nov 25, 2020

Detrusor Muscle Hyperactivity Trial in Worldwide (Botulinum toxin type A, Placebo)

Completed
Has Results
  • Detrusor Muscle Hyperactivity
  • Botulinum toxin type A
  • Placebo
  • Praha, Czechia
  • +16 more
Nov 4, 2020

Urinary Bladder, Overactive, Urodynamics, Effect of Drug Trial in Taipei (Intradetrusor Botox® (onabotulinumtoxinA) injection,

Recruiting
  • Urinary Bladder, Overactive
  • +2 more
  • Intradetrusor Botox® (onabotulinumtoxinA) injection
  • Combine Mirabegron and Solifenacin.
  • Taipei, Taiwan
    Mackay Memorial Hospital
Jul 29, 2023

Spinal Cord Injuries, Urinary Bladder, Overactive Trial in Nesoddtangen, Oslo (Onabotulinumtoxin A, Placebo)

Completed
  • Spinal Cord Injuries
  • Urinary Bladder, Overactive
  • Onabotulinumtoxin A
  • Placebo
  • Nesoddtangen, Norway
  • +1 more
Nov 22, 2022

Neurogenic Detrusor Overactivity Trial in Brussels (4 mg Fesoterodine ER tablet from Zwickau, 4 mg fesoterodine ER tablet from

Completed
  • Neurogenic Detrusor Overactivity
  • 4 mg Fesoterodine ER tablet from Zwickau
  • +3 more
  • Brussels, Bruxelles-capitale, Région DE, Belgium
    Brussels Clinical Research Unit
May 6, 2021

Portable Bladder Scanner to Determine Age/ Volume Specific

Completed
  • Neurogenic Bladder
  • +2 more
  • Bladder scan
  • Seoul, Korea, Republic of
    Seoul National University Hospital
May 11, 2021

Urodynamic Exam, Neurologic Disorder Trial in Paris (urodynamic exam in sitting and lying position)

Not yet recruiting
  • Urodynamic Exam
  • Neurologic Disorder
  • urodynamic exam in sitting and lying position
  • Paris, France
    Physical and Rehabilitation Medicine Pitié Salpêtrière Hospital
Jul 24, 2023

Autonomic Dysreflexia Trial in Vancouver (BOTOX)

Completed
  • Autonomic Dysreflexia
  • Vancouver, British Columbia, Canada
    International Collaboration on Repair Discoveries (ICORD)
Dec 20, 2019

Urinary Incontinence, Overactive Bladder Trial in Worldwide (Botulinum toxin type A, Placebo)

Terminated
Has Results
  • Urinary Incontinence
  • Overactive Bladder
  • Botulinum toxin type A
  • Placebo
  • Buenos Aires, Argentina
  • +81 more
Jul 1, 2021

Urinary Incontinence, Overactive Bladder Trial in Worldwide (Botulinum toxin type A, Placebo)

Terminated
Has Results
  • Urinary Incontinence
  • Overactive Bladder
  • Botulinum toxin type A
  • Placebo
  • Birmingham, Alabama
  • +80 more
Jul 1, 2021

Neurogenic Detrusor Overactivity Trial in Brussels (Fesoterodine BIC SR4 fasted (Treatment A in Part A, Treatment G in Part B),

Completed
  • Neurogenic Detrusor Overactivity
  • Fesoterodine BIC SR4 fasted (Treatment A in Part A, Treatment G in Part B)
  • +4 more
  • Brussels, Bruxelles-capitale, Région DE, Belgium
    Brussels Clinical Research Unit
Feb 8, 2021

Spinal Cord Injuries, Urinary Bladder, Neurogenic Trial in West Orange (Oxybutynin Chloride IR, Mirabegron)

Unknown status
  • Spinal Cord Injuries
  • Urinary Bladder, Neurogenic
  • West Orange, New Jersey
    Kessler Institute for Rehabilitation
Dec 14, 2019